<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1273" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1273/" /><meta name="ncbi_pagename" content="Alagille Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Alagille Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Alagille Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/12/12" /><meta name="citation_author" content="Nancy B Spinner" /><meta name="citation_author" content="Melissa A Gilbert" /><meta name="citation_author" content="Kathleen M Loomes" /><meta name="citation_author" content="Ian D Krantz" /><meta name="citation_pmid" content="20301450" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1273/" /><meta name="citation_keywords" content="Arteriohepatic Dysplasia" /><meta name="citation_keywords" content="Syndromic Bile Duct Paucity" /><meta name="citation_keywords" content="Arteriohepatic Dysplasia" /><meta name="citation_keywords" content="Syndromic Bile Duct Paucity" /><meta name="citation_keywords" content="Neurogenic locus notch homolog protein 2" /><meta name="citation_keywords" content="Protein jagged-1" /><meta name="citation_keywords" content="JAG1" /><meta name="citation_keywords" content="NOTCH2" /><meta name="citation_keywords" content="Alagille Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Alagille Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Nancy B Spinner" /><meta name="DC.Contributor" content="Melissa A Gilbert" /><meta name="DC.Contributor" content="Kathleen M Loomes" /><meta name="DC.Contributor" content="Ian D Krantz" /><meta name="DC.Date" content="2019/12/12" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1273/" /><meta name="description" content="Alagille syndrome (ALGS) is a multisystem disorder with a wide spectrum of clinical variability; this variability is seen even among individuals from the same family. The major clinical manifestations of ALGS are bile duct paucity on liver biopsy, cholestasis, congenital cardiac defects (primarily involving the pulmonary arteries), butterfly vertebrae, ophthalmologic abnormalities (most commonly posterior embryotoxon), and characteristic facial features. Renal abnormalities, growth failure, developmental delays, splenomegaly, and vascular abnormalities may also occur." /><meta name="og:title" content="Alagille Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Alagille syndrome (ALGS) is a multisystem disorder with a wide spectrum of clinical variability; this variability is seen even among individuals from the same family. The major clinical manifestations of ALGS are bile duct paucity on liver biopsy, cholestasis, congenital cardiac defects (primarily involving the pulmonary arteries), butterfly vertebrae, ophthalmologic abnormalities (most commonly posterior embryotoxon), and characteristic facial features. Renal abnormalities, growth failure, developmental delays, splenomegaly, and vascular abnormalities may also occur." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1273/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/alagille/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1273/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B0917E03F35B100000000090C0344.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1273_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1273_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ags/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/alexander/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1273_"><span class="title" itemprop="name">Alagille Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Arteriohepatic Dysplasia, Syndromic Bile Duct Paucity</div><p class="contrib-group"><span itemprop="author">Nancy B Spinner</span>, PhD, <span itemprop="author">Melissa A Gilbert</span>, PhD, <span itemprop="author">Kathleen M Loomes</span>, MD, and <span itemprop="author">Ian D Krantz</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1273_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1273_ai__"><div class="contrib half_rhythm"><span itemprop="author">Nancy B Spinner</span>, PhD<div class="affiliation small">Professor of Pathology and Laboratory Medicine, Perelman School of Medicine<br />University of Pennsylvania;<br />Professor of Pediatrics, Children's Hospital of Philadelphia<br />Philadelphia, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.pohc.liame@rennips" class="oemail">ude.pohc.liame@rennips</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Melissa A Gilbert</span>, PhD<div class="affiliation small">Manager, Translational Research<br />Division of Genomic Diagnostics<br />Department of Pathology and Laboratory Medicine<br />Children's Hospital of Philadelphia<br />Philadelphia, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.pohc.liame@amtreblig" class="oemail">ude.pohc.liame@amtreblig</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Kathleen M Loomes</span>, MD<div class="affiliation small">Professor of Pediatrics, Perelman School of Medicine<br />University of Pennsylvania;<br />Children&#x02019;s Hospital of Philadelphia<br />Philadelphia, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.pohc.liame@semool" class="oemail">ude.pohc.liame@semool</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Ian D Krantz</span>, MD<div class="affiliation small">Professor of Pediatrics and Genetics, Perelman School of Medicine<br />University of Pennsylvania;<br />Children's Hospital of Philadelphia<br />Philadelphia, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.nnepu.dem.liam@2nai" class="oemail">ude.nnepu.dem.liam@2nai</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 19, 2000</span>; Last Update: <span itemprop="dateModified">December 12, 2019</span>.</p><p><em>Estimated reading time: 25 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="alagille.Summary" itemprop="description"><h2 id="_alagille_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Alagille syndrome (ALGS) is a multisystem disorder with a wide spectrum of clinical variability; this variability is seen even among individuals from the same family. The major clinical manifestations of ALGS are bile duct paucity on liver biopsy, cholestasis, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cardiac defects (primarily involving the pulmonary arteries), butterfly vertebrae, ophthalmologic abnormalities (most commonly posterior embryotoxon), and characteristic facial features. Renal abnormalities, growth failure, developmental delays, splenomegaly, and vascular abnormalities may also occur.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of ALGS is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who meets clinical diagnostic criteria and/or has a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>JAG1</i> or <i>NOTCH2</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Management by a multidisciplinary team according to clinical manifestations (clinical genetics, gastroenterology, nutrition, cardiology, ophthalmology, nephrology, transplant hepatology, and child development); choloretic agents (ursodeoxycholic acid), other medications (cholestyramine, rifampin, naltrexone); liver transplantation for end-stage liver disease; standard treatment for cardiac, renal, and neurologic involvement.</p><p><i>Surveillance</i>: Regular monitoring by cardiology, gastroenterology, and nutrition specialists.</p><p><i>Agents/circumstances to avoid</i>: Contact sports; alcohol consumption if liver disease is present.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>ALGS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Approximately 30%-50% of individuals have an inherited <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and about 50%-70% have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant. Parental somatic/<a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> has been reported. Each child of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual is at a 50% risk of inheriting the ALGS-related genetic alteration and developing signs of ALGS. Prenatal testing for pregnancies at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-testing/">preimplantation genetic testing</a> are possible if the causative genetic alteration has been identified in an affected family member. Because ALGS is associated with highly <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> with clinical features ranging from subclinical to severe, clinical manifestations cannot be predicted by molecular genetic prenatal testing.</p></div></div><div id="alagille.Diagnosis"><h2 id="_alagille_Diagnosis_">Diagnosis</h2><div id="alagille.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Alagille syndrome (ALGS) <b>should be suspected</b> in individuals with the following findings [<a class="bk_pop" href="#alagille.REF.mitchell.2018.625">Mitchell et al 2018</a>]:</p><ul><li class="half_rhythm"><div>The histologic finding of <b>bile duct paucity</b> (an increased portal tract-to-bile duct ratio) on liver biopsy. Although considered to be the most important and constant feature of ALGS, bile duct paucity is not present in infancy in many individuals ultimately shown to have ALGS. In the newborn, a normal ratio of portal tracts to bile ducts, bile duct proliferation, or a picture suggestive of neonatal hepatitis may be observed. Overall, bile duct paucity is present in about 90% of individuals.</div></li><li class="half_rhythm"><div>Three of the following five major clinical features (in addition to bile duct paucity):</div><ul><li class="half_rhythm"><div><b>Cholestasis</b></div></li><li class="half_rhythm"><div><b>Cardiac defect</b> (most commonly stenosis of the peripheral pulmonary artery and its branches)</div></li><li class="half_rhythm"><div><b>Skeletal abnormalities</b> (most commonly butterfly vertebrae identified in AP chest radiographs)</div></li><li class="half_rhythm"><div><b>Ophthalmologic abnormalities</b> (most commonly posterior embryotoxon</div></li><li class="half_rhythm"><div><b>Characteristic facial features</b> (most commonly, triangular-shaped face with a broad forehead and a pointed chin, bulbous tip of the nose, deeply set eyes, and hypertelorism; see <a class="figpopup" href="/books/NBK1273/figure/alagille.F1/?report=objectonly" target="object" rid-figpopup="figalagilleF1" rid-ob="figobalagilleF1">Figure 1</a>)</div></li></ul></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figalagilleF1" co-legend-rid="figlgndalagilleF1"><a href="/books/NBK1273/figure/alagille.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figalagilleF1" rid-ob="figobalagilleF1"><img class="small-thumb" src="/books/NBK1273/bin/alagille-Image001.gif" src-large="/books/NBK1273/bin/alagille-Image001.jpg" alt="Figure 1. . Typical facial features of Alagille syndrome." /></a><div class="icnblk_cntnt" id="figlgndalagilleF1"><h4 id="alagille.F1"><a href="/books/NBK1273/figure/alagille.F1/?report=objectonly" target="object" rid-ob="figobalagilleF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Typical facial features of Alagille syndrome. Note broad forehead, deeply set eyes, and pointed chin. </p></div></div><p><b>Individuals with an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> relative.</b> The diagnosis of ALGS should also be suspected in individuals who do not meet the full clinical criteria but do have an affected relative. If an affected <a class="def" href="/books/n/gene/glossary/def-item/first-degree-relative/">first-degree relative</a> is identified, the presence of one or more features is considered sufficient to make the diagnosis on clinical grounds.</p></div><div id="alagille.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of Alagille syndrome (ALGS) <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who meets the clinical diagnostic criteria, and can be further confirmed by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>JAG1</i> or <i>NOTCH2</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1273/table/alagille.T.molecular_genetic_testing_use/?report=objectonly" target="object" rid-figpopup="figalagilleTmoleculargenetictestinguse" rid-ob="figobalagilleTmoleculargenetictestinguse">Table 1</a>).</p><p>Note: A very small subset (3.2%) of individuals with a clinical diagnosis of ALGS do not have an identified <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in either <i>JAG1</i> or <i>NOTCH2</i> [<a class="bk_pop" href="#alagille.REF.gilbert.2019.2197">Gilbert et al 2019</a>].</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (serial single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of ALGS is broad, individuals with the distinctive findings described in <a href="#alagille.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#alagille.Option_1">Option 1</a>), whereas those in whom the diagnosis of ALGS has not been considered are more likely to be diagnosed using genomic testing (see <a href="#alagille.Option_2">Option 2</a>).</p><div id="alagille.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of ALGS, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>JAG1</i> and <i>NOTCH2</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; depending on the method used, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications may not be detected. Sequence analysis of <i>JAG1</i> is performed first. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> of <i>JAG1</i> is performed to detect intragenic deletions or duplications. <i>NOTCH2</i> <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> should be considered when the diagnosis is strongly suspected on clinical grounds, but no <i>JAG1</i> pathogenic variant (by either sequence or deletion/duplication analysis) was identified.</div><div class="half_rhythm">Note: (1) If a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> involving the entire <i>JAG1</i> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is identified, a full <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> study may be considered to determine if a rare <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement (<a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> or inversion) is present. (2) The presence of developmental delay and/or hearing loss in addition to the features commonly seen in ALGS may increase the suspicion of a chromosome deletion, and a <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis (CMA) would be recommended.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>JAG1</i>, <i>NOTCH2</i>, and other genes of interest (see <a href="#alagille.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For this disorder a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that also includes <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> is recommended (see <a class="figpopup" href="/books/NBK1273/table/alagille.T.molecular_genetic_testing_use/?report=objectonly" target="object" rid-figpopup="figalagilleTmoleculargenetictestinguse" rid-ob="figobalagilleTmoleculargenetictestinguse">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="alagille.Option_2"><h4>Option 2</h4><p>When the diagnosis of ALGS is not considered because an individual does not meet the clinical diagnostic criteria, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>If <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic, <b><a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a></b> (when clinically available) may be considered to detect (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="alagille.T.molecular_genetic_testing_use" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Alagille Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1273/table/alagille.T.molecular_genetic_testing_use/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__alagille.T.molecular_genetic_testing_use_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_alagille.T.molecular_genetic_testing_use_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_alagille.T.molecular_genetic_testing_use_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th><th id="hd_h_alagille.T.molecular_genetic_testing_use_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_alagille.T.molecular_genetic_testing_use_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of ALGS<br />Attributed to Pathogenic<br />Variants in Gene</th><th id="hd_h_alagille.T.molecular_genetic_testing_use_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>3</sup> Detectable by Method</th></tr><tr><th headers="hd_h_alagille.T.molecular_genetic_testing_use_1_1_1_3" id="hd_h_alagille.T.molecular_genetic_testing_use_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></th><th headers="hd_h_alagille.T.molecular_genetic_testing_use_1_1_1_3" id="hd_h_alagille.T.molecular_genetic_testing_use_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></th></tr></thead><tbody><tr><td headers="hd_h_alagille.T.molecular_genetic_testing_use_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>JAG1</i></td><td headers="hd_h_alagille.T.molecular_genetic_testing_use_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">94.3%&#x000a0;<sup>6</sup></td><td headers="hd_h_alagille.T.molecular_genetic_testing_use_1_1_1_3 hd_h_alagille.T.molecular_genetic_testing_use_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">88%&#x000a0;<sup>6</sup></td><td headers="hd_h_alagille.T.molecular_genetic_testing_use_1_1_1_3 hd_h_alagille.T.molecular_genetic_testing_use_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12%&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_alagille.T.molecular_genetic_testing_use_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NOTCH2</i></td><td headers="hd_h_alagille.T.molecular_genetic_testing_use_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2.5&#x000a0;<sup>6</sup></td><td headers="hd_h_alagille.T.molecular_genetic_testing_use_1_1_1_3 hd_h_alagille.T.molecular_genetic_testing_use_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%&#x000a0;<sup>6</sup></td><td headers="hd_h_alagille.T.molecular_genetic_testing_use_1_1_1_3 hd_h_alagille.T.molecular_genetic_testing_use_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_alagille.T.molecular_genetic_testing_use_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8</sup></td><td headers="hd_h_alagille.T.molecular_genetic_testing_use_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3.2%&#x000a0;<sup>6</sup></td><td headers="hd_h_alagille.T.molecular_genetic_testing_use_1_1_1_3 hd_h_alagille.T.molecular_genetic_testing_use_1_1_2_1 hd_h_alagille.T.molecular_genetic_testing_use_1_1_2_2" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="alagille.TF.1.1"><p class="no_margin">Genes are listed in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="alagille.TF.1.2"><p class="no_margin">See <a href="/books/NBK1273/#alagille.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="alagille.TF.1.3"><p class="no_margin">See <a href="#alagille.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>4. </dt><dd><div id="alagille.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="alagille.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications. Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="alagille.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#alagille.REF.gilbert.2019.2197">Gilbert et al [2019]</a></p></div></dd><dt>7. </dt><dd><div id="alagille.TF.1.7"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd><dt>8. </dt><dd><div id="alagille.TF.1.8"><p class="no_margin">Individuals with a clinical diagnosis of ALGS but without a detectable <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in either <i>JAG1</i> or <i>NOTCH2</i> have been hypothesized to have a pathogenic variant in <i>JAG1</i> or <i>NOTCH2</i> that is not yet detectable with current <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> [Authors, personal observation]. It is also possible that another <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> related to the Notch signaling pathway, or a variant in an untranslated regulatory region, may be responsible, although this has not yet been reported.</p></div></dd></dl></div></div></div></div></div></div><div id="alagille.Clinical_Characteristics"><h2 id="_alagille_Clinical_Characteristics_">Clinical Characteristics</h2><div id="alagille.Clinical_Description"><h3>Clinical Description</h3><p>Alagille syndrome (ALGS) is a multisystem disorder with a wide spectrum of clinical variability ranging from life-threatening liver or cardiac disease to only subclinical manifestations (i.e., butterfly vertebrae, posterior embryotoxon, or characteristic facial features) [<a class="bk_pop" href="#alagille.REF.guegan.2012.33">Guegan et al 2012</a>]. This variability is seen even among individuals from the same family [<a class="bk_pop" href="#alagille.REF.kamath.2003.891">Kamath et al 2003</a>].</p><p>Individuals with ALGS who have severe liver or cardiac involvement are most often diagnosed in infancy. In those individuals with subclinical or mild hepatic manifestations, the diagnosis may not be established until later in life.</p><p>To date, more than 700 individuals with ALGS have been found to have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>JAG1 or NOTCH2</i> [<a class="bk_pop" href="#alagille.REF.gilbert.2019.2197">Gilbert et al 2019</a>]. <a class="figpopup" href="/books/NBK1273/table/alagille.T.features_of_alagille_syndrome/?report=objectonly" target="object" rid-figpopup="figalagilleTfeaturesofalagillesyndrome" rid-ob="figobalagilleTfeaturesofalagillesyndrome">Table 2</a> lists the phenotypic features associated with this condition based on reports by <a class="bk_pop" href="#alagille.REF.emerick.1999.822">Emerick et al [1999]</a>, <a class="bk_pop" href="#alagille.REF.subramaniam.2011.84">Subramaniam et al [2011]</a>, and <a class="bk_pop" href="#alagille.REF.saleh.2016.75">Saleh et al [2016]</a>.</p><div id="alagille.T.features_of_alagille_syndrome" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Features of Alagille Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1273/table/alagille.T.features_of_alagille_syndrome/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__alagille.T.features_of_alagille_syndrome_lrgtbl__"><table><thead><tr><th id="hd_h_alagille.T.features_of_alagille_syndrome_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Feature</th><th id="hd_h_alagille.T.features_of_alagille_syndrome_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">% of Persons w/Feature</th><th id="hd_h_alagille.T.features_of_alagille_syndrome_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_alagille.T.features_of_alagille_syndrome_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hepatic abnormality incl: bile duct paucity; conjugated hyperbilirubinemia; chronic cholestasis characterized by pruritus, xanthomas &#x00026; fat-soluble vitamin deficiencies; &#x00026; end-stage liver disease</td><td headers="hd_h_alagille.T.features_of_alagille_syndrome_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;100%</td><td headers="hd_h_alagille.T.features_of_alagille_syndrome_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_alagille.T.features_of_alagille_syndrome_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cardiac malformation</td><td headers="hd_h_alagille.T.features_of_alagille_syndrome_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">90%-97%</td><td headers="hd_h_alagille.T.features_of_alagille_syndrome_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Most common cardiovascular malformations incl pulmonary stenosis &#x00026; tetralogy of Fallot</td></tr><tr><td headers="hd_h_alagille.T.features_of_alagille_syndrome_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Posterior embryotoxon</td><td headers="hd_h_alagille.T.features_of_alagille_syndrome_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">78%-89%</td><td headers="hd_h_alagille.T.features_of_alagille_syndrome_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_alagille.T.features_of_alagille_syndrome_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Renal disease</td><td headers="hd_h_alagille.T.features_of_alagille_syndrome_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">39%</td><td headers="hd_h_alagille.T.features_of_alagille_syndrome_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_alagille.T.features_of_alagille_syndrome_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Vertebral anomalies</td><td headers="hd_h_alagille.T.features_of_alagille_syndrome_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">33%-93%</td><td headers="hd_h_alagille.T.features_of_alagille_syndrome_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_alagille.T.features_of_alagille_syndrome_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Characteristic facies</td><td headers="hd_h_alagille.T.features_of_alagille_syndrome_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">77%-97%</td><td headers="hd_h_alagille.T.features_of_alagille_syndrome_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div></div><p><b>Hepatic manifestations.</b> While some individuals with <i>JAG1</i> or <i>NOTCH2</i> pathogenic variants have no detectable hepatic manifestations [<a class="bk_pop" href="#alagille.REF.gurkan.1999.416">Gurkan et al 1999</a>, <a class="bk_pop" href="#alagille.REF.krantz.1999.56">Krantz et al 1999</a>, <a class="bk_pop" href="#alagille.REF.kamath.2003.891">Kamath et al 2003</a>], in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> people liver disease presents within the first three months of life. The severity of liver disease ranges from asymptomatic elevations of liver enzymes to jaundice, chronic cholestasis, and end-stage liver disease.</p><p>Jaundice and conjugated hyperbilirubinemia may be present in the neonatal period. Increased serum concentrations of bile acids, alkaline phosphatase, gamma-glutamyl transpeptidase (GGT), triglycerides, and the aminotransferases are also commonly observed. Impaired bile salt secretion can lead to fat-soluble vitamin deficiencies and malnutrition.</p><p>Cholestasis manifests as pruritus, increased serum concentration of bile acids, growth failure, and xanthomas.</p><p>Various reports indicate that between 20% and 70% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals will require a liver transplant by age 18 years due to liver failure or severe pruritus [<a class="bk_pop" href="#alagille.REF.lykavieris.2001.431">Lykavieris et al 2001</a>; <a class="bk_pop" href="#alagille.REF.kamath.2012c.940">Kamath et al 2012c</a>; Author, unpublished observation]. Currently, it is not possible to predict which individuals will progress to end-stage liver disease, although work is ongoing to identify biomarkers that will help predict clinical disease course [<a class="bk_pop" href="#alagille.REF.thakurdas.2016.550">Thakurdas et al 2016</a>, <a class="bk_pop" href="#alagille.REF.tsai.2016.663">Tsai et al 2016</a>, <a class="bk_pop" href="#alagille.REF.adams.2019">Adams et al 2019</a>]. While it is difficult to predict whether a child with cholestasis will have improvement or progression of liver disease, a retrospective study of 144 individuals with Alagille syndrome found that serum total bilirubin greater than 3.8 mg/dL can be predictive of worsened long-term hepatic outcomes in children between the ages of 12 and 24 months [<a class="bk_pop" href="#alagille.REF.mouzaki.2016.755">Mouzaki et al 2016</a>].</p><p>Liver biopsy typically shows paucity of the intrahepatic bile ducts, which may be progressive. In infants younger than age six months, bile duct paucity is not always present and the liver biopsy may demonstrate ductal proliferation, resulting in the possible misdiagnosis of ALGS as biliary atresia.</p><p><b>Cardiac manifestations.</b> Cardiac findings, which can include significant structural defects, occur in 90%-97% of individuals with ALGS [<a class="bk_pop" href="#alagille.REF.emerick.1999.822">Emerick et al 1999</a>, <a class="bk_pop" href="#alagille.REF.mcelhinney.2002.2567">McElhinney et al 2002</a>, <a class="bk_pop" href="#alagille.REF.tretter.2018">Tretter &#x00026; McElhinney 2018</a>]. The pulmonary vasculature (pulmonary valve, pulmonary artery, and its branches) is most commonly involved. Pulmonic stenosis (peripheral and branch) is the most common cardiac finding (67%) [<a class="bk_pop" href="#alagille.REF.emerick.1999.822">Emerick et al 1999</a>]. The most common complex cardiac defect is tetralogy of Fallot, seen in 7%-16% of individuals [<a class="bk_pop" href="#alagille.REF.emerick.1999.822">Emerick et al 1999</a>]. Other cardiac malformations include (in order of decreasing frequency) ventricular septal defect, atrial septal defect, aortic stenosis, and coarctation of the aorta.</p><p><b>Ophthalmologic manifestations.</b> The most common ophthalmologic finding in individuals with ALGS is posterior embryotoxon. Posterior embryotoxon, a prominent Schwalbe's ring, is a defect of the anterior chamber of the eye and has been reported in 78%-89% of individuals with ALGS [<a class="bk_pop" href="#alagille.REF.emerick.1999.822">Emerick et al 1999</a>, <a class="bk_pop" href="#alagille.REF.hingorani.1999.330">Hingorani et al 1999</a>]. Most accurately identified on slit lamp examination, posterior embryotoxon does not affect visual acuity but is useful as a diagnostic aid. Posterior embryotoxon is also present in approximately 8%-15% of individuals from the general population. This finding in family members who are otherwise unaffected can complicate the identification of relatives with the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</p><p>Other defects of the anterior chamber seen in ALGS include Axenfeld anomaly and Rieger anomaly. Ocular ultrasonographic examination in 20 children with ALGS found optic disk drusen in 90%. Retinal pigmentary changes are also common (32% in one study) [<a class="bk_pop" href="#alagille.REF.hingorani.1999.330">Hingorani et al 1999</a>, <a class="bk_pop" href="#alagille.REF.elkoofy.2011.199">El-Koofy et al 2011</a>]. Additional eye anomalies have also been described [<a class="bk_pop" href="#alagille.REF.makino.2012.1445">Makino et al 2012</a>].</p><p>The visual prognosis is good, although mild decreases in visual acuity may occur and, in very rare instances, associated <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> intracranial hypertension has also been identified in individuals with ALGS, although the pathogenesis for increased intracranial pressure has not been described [<a class="bk_pop" href="#alagille.REF.narula.2006.348">Narula et al 2006</a>, <a class="bk_pop" href="#alagille.REF.mouzaki.2010.1006">Mouzaki et al 2010</a>].</p><p><b>Skeletal manifestations.</b> The most common radiographic finding is butterfly vertebrae, a clefting abnormality of the vertebral bodies that occurs most commonly in the thoracic vertebrae. The frequency of butterfly vertebrae reported in individuals with ALGS ranges from 33% to 93% [<a class="bk_pop" href="#alagille.REF.emerick.1999.822">Emerick et al 1999</a>, <a class="bk_pop" href="#alagille.REF.sanderson.2002.114">Sanderson et al 2002</a>, <a class="bk_pop" href="#alagille.REF.lin.2012.1005">Lin et al 2012</a>]. Butterfly vertebrae are usually asymptomatic. The incidence in the general population is unknown but suspected to be low. Other skeletal manifestations in individuals with ALGS have been reported less frequently [<a class="bk_pop" href="#alagille.REF.zanotti.2010.886">Zanotti &#x00026; Canalis 2010</a>].</p><p><b>Facial features.</b> The constellation of facial features observed in children with ALGS includes a broad forehead, deeply set eyes with moderate hypertelorism, pointed chin, and a concave or straight nasal ridge with a bulbous tip. These features give the face the appearance of an inverted triangle. The typical facial features are almost universally present in Alagille syndrome (see <a class="figpopup" href="/books/NBK1273/figure/alagille.F1/?report=objectonly" target="object" rid-figpopup="figalagilleF1" rid-ob="figobalagilleF1">Figure 1</a>).</p><p>Although the facial <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in ALGS is specific to the syndrome and is often a powerful diagnostic tool, Lin et al showed that North American dysmorphologists had difficulty assessing the facial features in a cohort of Vietnamese children with Alagille syndrome, suggesting that the value of this diagnostic tool is variable across populations [<a class="bk_pop" href="#alagille.REF.lin.2012.1005">Lin et al 2012</a>].</p><p><b>Renal abnormalities,</b> both structural (small hyperechoic kidney, ureteropelvic obstruction, renal cysts) and functional (most commonly renal tubular acidosis), are found in 39% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (73/187) [<a class="bk_pop" href="#alagille.REF.kamath.2012b.85">Kamath et al 2012b</a>, <a class="bk_pop" href="#alagille.REF.romero.2018">Romero 2018</a>]. Hypertension and renal artery stenosis have also been noted in adults with ALGS [<a class="bk_pop" href="#alagille.REF.salem.2012.1300">Salem et al 2012</a>].</p><p><b>Other features</b></p><ul><li class="half_rhythm"><div>Growth failure has been observed in up to 50%-90% of individuals with ALGS; although not well understood, it has been attributed to malnutrition/malabsorption as well as cholestasis [<a class="bk_pop" href="#alagille.REF.emerick.1999.822">Emerick et al 1999</a>, <a class="bk_pop" href="#alagille.REF.arvay.2005.146">Arvay et al 2005</a>, <a class="bk_pop" href="#alagille.REF.kamath.2015.390">Kamath et al 2015</a>].</div></li><li class="half_rhythm"><div>Delayed puberty and high-pitched voice [<a class="bk_pop" href="#alagille.REF.turnpenny.2012.251">Turnpenny &#x00026; Ellard 2012</a>]</div></li><li class="half_rhythm"><div>Mild delays of gross motor skills, identified in 16% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Mild intellectual disability was identified in 2% by <a class="bk_pop" href="#alagille.REF.emerick.1999.822">Emerick et al [1999]</a>.</div></li><li class="half_rhythm"><div>Splenomegaly [<a class="bk_pop" href="#alagille.REF.emerick.1999.822">Emerick et al 1999</a>, <a class="bk_pop" href="#alagille.REF.subramaniam.2011.84">Subramaniam et al 2011</a>].</div></li><li class="half_rhythm"><div>Vascular abnormalities:</div><ul><li class="half_rhythm"><div>Neurovascular accidents, reported at rates as high as 15% [<a class="bk_pop" href="#alagille.REF.emerick.1999.822">Emerick et al 1999</a>], accounted for 34% of mortality in one large study [<a class="bk_pop" href="#alagille.REF.kamath.2004.1354">Kamath et al 2004</a>].</div></li><li class="half_rhythm"><div>Renovascular anomalies, middle aortic syndrome, and moyamoya syndrome [<a class="bk_pop" href="#alagille.REF.woolfenden.1999.505">Woolfenden et al 1999</a>, <a class="bk_pop" href="#alagille.REF.rocha.2012.125">Rocha et al 2012</a>] have been reported.</div></li><li class="half_rhythm"><div>Anomalies of the basilar, carotid, and middle cerebral arteries also occur [<a class="bk_pop" href="#alagille.REF.kamath.2004.1354">Kamath et al 2004</a>, <a class="bk_pop" href="#alagille.REF.emerick.2005.99">Emerick et al 2005</a>].</div></li></ul></li><li class="half_rhythm"><div>Craniosynostosis (unilateral coronal) has been reported in 0.9% of individuals with ALGS, compared to 0.03% in the normal population. [<a class="bk_pop" href="#alagille.REF.kamath.2002.176">Kamath et al 2002</a>, <a class="bk_pop" href="#alagille.REF.yilmaz.2013.146">Yilmaz et al 2013</a>]</div></li><li class="half_rhythm"><div>High risk for bone fractures with significant bone mineral deficiency, quantified by dual-energy x-ray absorptiometry (DXA) analysis [<a class="bk_pop" href="#alagille.REF.loomes.2019.245">Loomes et al 2019</a>]</div></li></ul><p><b>Life span</b> in ALGS is reduced, with the primary cause of death occurring from cardiac disease, severe liver disease, and intracranial bleeding [<a class="bk_pop" href="#alagille.REF.emerick.1999.822">Emerick et al 1999</a>, <a class="bk_pop" href="#alagille.REF.kamath.2004.1354">Kamath et al 2004</a>, <a class="bk_pop" href="#alagille.REF.cho.2015.552">Cho et al 2015</a>]. Most studies do not include long-term follow up; thus, information about life span among those with ALGS is not available.</p></div><div id="alagille.Phenotype_Correlations_by_Gene"><h3>Phenotype Correlations by Gene</h3><p>Although very few patients with <i>NOTCH2</i> variants have been described to date, it has been reported that individuals with pathogenic <i>NOTCH2</i> variants have a lower prevalence of cardiac, vertebral, and facial anomalies than those with pathogenic <i>JAG1</i> variants [<a class="bk_pop" href="#alagille.REF.kamath.2012a.138">Kamath et al 2012a</a>].</p></div><div id="alagille.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> for <i>JAG1</i> or <i>NOTCH2</i> have been identified.</p><p>Individuals with ALGS with additional abnormalities, including developmental delay, hearing loss, and autism may have a larger <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 20p12 encompassing the entire <i>JAG1</i> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> as well as other genes in the region [<a class="bk_pop" href="#alagille.REF.kamath.2009.371">Kamath et al 2009</a>].</p></div><div id="alagille.Penetrance"><h3>Penetrance</h3><p>ALGS associated with pathogenic variants in either of the known causative genes (<i>JAG1</i> and <i>NOTCH2</i>) demonstrates highly <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> with clinical features ranging from subclinical to severe.</p><p><b><i>JAG1</i> pathogenic variants.</b> To determine the range and frequency of clinical findings in individuals with a <i>JAG1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and hence, the <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, <a class="bk_pop" href="#alagille.REF.kamath.2003.891">Kamath et al [2003]</a> studied 53 <i>JAG1</i> variant-confirmed relatives of probands with ALGS. Their findings identified two such individuals with no features of ALGS &#x02013; a 96% penetrance rate.</p><p><b><i>NOTCH2</i> pathogenic variants.</b> Penetrance appears complete in the individuals so far identified with <i>NOTCH2</i> pathogenic variants. [<a class="bk_pop" href="#alagille.REF.kamath.2012a.138">Kamath et al 2012a</a>, <a class="bk_pop" href="#alagille.REF.gilbert.2019.2197">Gilbert et al 2019</a>].</p></div><div id="alagille.Prevalence"><h3>Prevalence</h3><p>The prevalence of ALGS is estimated at 1:30,000-1:50,000 live births [<a class="bk_pop" href="#alagille.REF.saleh.2016.75">Saleh et al 2016</a>]. Advances in molecular testing have aided in increasing the detection rate for the disease; however, due to the variable <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, it likely remains underdiagnosed [<a class="bk_pop" href="#alagille.REF.kamath.2003.891">Kamath et al 2003</a>]. The prevalence across populations appears to be stable.</p></div></div><div id="alagille.Genetically_Related_Allelic_Dis"><h2 id="_alagille_Genetically_Related_Allelic_Dis_">Genetically Related (Allelic) Disorders</h2><p><b><i>JAG1</i></b></p><ul><li class="half_rhythm"><div>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>JAG1</i>.</div></li><li class="half_rhythm"><div>Note: Some individuals with pathogenic variants in <i>JAG1</i> may express only some of the features of Alagille syndrome (ALGS) and may not be recognized as having this diagnosis. The most clinically significant group is individuals with apparently <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> cardiac disease who have <i>JAG1</i> pathogenic variants [<a class="bk_pop" href="#alagille.REF.krantz.1998.1361">Krantz et al 1998</a>, <a class="bk_pop" href="#alagille.REF.eldadah.2001.163">Eldadah et al 2001</a>, <a class="bk_pop" href="#alagille.REF.bauer.2010.594">Bauer et al 2010</a>, <a class="bk_pop" href="#alagille.REF.rauch.2010.321">Rauch et al 2010</a>].</div></li></ul><p><b><i>NOTCH2</i></b></p><ul><li class="half_rhythm"><div>Specific <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>NOTCH2</i> are known to be associated with Hajdu-Cheney syndrome (serpentine fibula polycystic kidney syndrome; OMIM <a href="https://omim.org/entry/102500" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">102500</a>). Hajdu-Cheney syndrome is an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> disorder which causes focal bone destruction, osteoporosis, craniofacial dysmorphology, renal cysts, cleft palate, and cardiac defects. The <i>NOTCH2</i> pathogenic variants identified in individuals with Hadju-Cheney syndrome were all localized in the last <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> (exon 34) of <i>NOTCH2.</i></div></li><li class="half_rhythm"><div>Note: Some individuals with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>NOTCH2</i> may express only some of the features of ALGS and may not be recognized as having this diagnosis [<a class="bk_pop" href="#alagille.REF.kamath.2012a.138">Kamath et al 2012a</a>].</div></li><li class="half_rhythm"><div>Splenic marginal zone lymphoma (SMZL) occurring in the absence of any findings of ALGS may harbor somatic variants in <i>NOTCH2</i> that are <b>not</b> present in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>. In these circumstances predisposition to SMZL is not heritable [<a class="bk_pop" href="#alagille.REF.kiel.2012.1553">Kiel et al 2012</a>]. For more information see <a href="#alagille.Cancer_and_Benign_Tumors">Cancer and Benign Tumors</a>.</div></li></ul></div><div id="alagille.Differential_Diagnosis"><h2 id="_alagille_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Bile duct paucity</b> is not seen exclusively in Alagille syndrome (ALGS). Other causes of bile duct paucity include: <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> metabolic disorders (<a href="/books/n/gene/alpha1-a/">alpha-1-antitrypsin deficiency</a>, hypopituitarism, <a href="/books/n/gene/cf/">cystic fibrosis</a>, trihydroxycoprostanic acid excess), <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> abnormalities (Down syndrome), infectious diseases (<a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> CMV, congenital rubella, congenital syphilis, hepatitis B), immunologic disorders (graft-versus-host disease, chronic hepatic allograft rejection, primary sclerosing cholangitis), and others (<a href="/books/n/gene/pbd/">Zellweger spectrum disorder</a>, Ivemark syndrome). These can be distinguished from ALGS by history, by the presence of other findings, or by genetic testing.</p><p>Inherited disorders associated with <b>intrahepatic cholestasis</b> include <a href="/books/n/gene/alpha1-a/">alpha-1-antitrypsin deficiency</a>, progressive <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> intrahepatic cholestasis (including <a href="/books/n/gene/pfic/">progressive familial intrahepatic cholestasis 1 and 2</a> [Byler syndrome]), inborn errors of bile acid metabolism, neonatal sclerosing cholangitis, Norwegian cholestasis (Aagenaes syndrome) and North American Indian cholestasis (NAIC). These conditions are largely confined to the liver but some are associated with extrahepatic manifestations.</p><p><b>Neonatal cholestasis.</b> More than 100 specific causes of neonatal cholestasis exist. Differential diagnosis depends on clinical presentation and includes infectious, metabolic, genetic, or endocrine disorders as well as structural anomalies. Evaluation typically focuses on treatable causes including sepsis, hypothyroidism, and single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> disorders such as <a href="/books/n/gene/galactosemia/">classic galactosemia</a>. Biliary atresia is the most common identifiable cause of neonatal cholestasis and should be diagnosed early since surgical intervention at a young age is associated with better outcomes.</p><p><b>Posterior embryotoxon</b> can be seen in a number of genetic disorders, but is a frequent finding in Axenfeld-Rieger syndrome. It is also observed in 8%-15% of the general population. ALGS can be distinguished by the presence of other findings or by genetic testing.</p><p><b>Pulmonic vascular system abnormalities</b> are seen in isolation as well as in syndromes such as <a href="/books/n/gene/noonan/">Noonan syndrome</a>, Watson syndrome (pulmonic stenosis and <a href="/books/n/gene/nf1/">neurofibromatosis type 1</a>), <a href="/books/n/gene/leopard/">Noonan syndrome with multiple lentigines</a>, Down syndrome, and <a href="/books/n/gene/williams/">Williams syndrome</a>. These other syndromes can be distinguished by other associated clinical findings and/or molecular genetic or <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> testing.</p><p>Several of the <b>cardiac defects</b> described in ALGS, particularly ventricular septal defect and tetralogy of Fallot, are commonly seen in individuals with <a href="/books/n/gene/gr_22q11deletion/">deletion 22q11.2 syndrome</a>. Individuals with this diagnosis have also been reported as having butterfly vertebrae and poor growth, two common features of ALGS. Liver disease is not part of the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> 22q11.2 syndrome; genetic testing can be used to distinguish the two disorders.</p><div id="alagille.T.genes_of_interest_in_the_diff" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Genes of Interest in the Differential Diagnosis of Alagille Syndrome (ALGS)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1273/table/alagille.T.genes_of_interest_in_the_diff/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__alagille.T.genes_of_interest_in_the_diff_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Key<br />Overlapping<br />Clinical<br />Feature</th><th id="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th></tr></thead><tbody><tr><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_1" rowspan="6" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Bile duct<br />paucity</td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AMACR</i></td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Trihydroxycoprostanic acid excess (OMIM <a href="https://omim.org/entry/214950" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">214950</a>)</td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>CFTR</i></td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/cf/">Cystic fibrosis</a></td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>GDF1</i></td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ivemark syndrome (OMIM <a href="https://omim.org/entry/208530" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">208530</a>)</td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>NEK8</i></td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Renal-hepatic-pancreatic-dysplasia 2 (OMIM <a href="https://omim.org/entry/615415" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615415</a>)</td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>PEX1</i>, <i>PEX6</i>, <i>PEX12</i>&#x000a0;<sup>1</sup></td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pbd/">Zellweger spectrum disorder</a></td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>SERPINA1</i></td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/alpha1-a/">Alpha-1-antitrypsin deficiency</a></td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Intrahepatic<br />cholestasis</td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ABCB4</i></td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Progressive <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> intrahepatic cholestasis 3 (OMIM <a href="https://omim.org/entry/602347" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">602347</a>)</td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_2" rowspan="2" colspan="1" scope="row" style="text-align:left;vertical-align:middle;"><i>ABCB11</i>, <i>ATP8B1</i></td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Progressive <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> intrahepatic cholestasis 1 &#x00026; 2 (see <a href="/books/n/gene/pfic/">ATP8B1 Deficiency</a>)</td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Benign recurrent intrahepatic cholestasis (OMIM <a href="https://omim.org/phenotypicSeries/PS243300" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PS243300</a>)</td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neonatal<br />cholestasis</td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GALT</i></td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/galactosemia/">Classic galactosemia</a></td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Posterior<br />embryotoxon</td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FOXC1</i>, <i>PITX2</i></td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Axenfeld-Rieger syndrome (OMIM <a href="https://omim.org/phenotypicSeries/PS180500" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PS180500</a>)</td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Pulmonic<br />vascular system<br />abnormalities</td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ELN</i></td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/williams/">Williams syndrome</a></td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>NF1</i></td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Watson syndrome (pulmonic stenosis &#x00026; <a href="/books/n/gene/nf1/">neurofibromatosis type 1</a>)</td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>PTPN11</i>, <i>SOS1</i>, <i>RAF1</i>, <i>RIT1</i>&#x000a0;<sup>2</sup></td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/noonan/">Noonan syndrome</a></td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD<br />(AR&#x000a0;<sup>3</sup>)</td></tr><tr><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>PTPN11</i>, <i>RAF1</i>, <i>BRAF</i>, <i>MAP2K1</i></td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/leopard/">Noonan syndrome with multiple lentigines</a></td><td headers="hd_h_alagille.T.genes_of_interest_in_the_diff_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt>1. </dt><dd><div id="alagille.TF.3.1"><p class="no_margin">Biallelic pathogenic variants in <i>PEX1</i>, <i>PEX6</i>, and <i>PEX12</i> account for 60.5%, 14.5%, and 7.6% of Zellweger spectrum disorder (ZSD), respectively. Thirteen genes are known to be associated with ZSD (see <a href="/books/n/gene/pbd/">Zellweger Spectrum Disorder</a>).</p></div></dd><dt>2. </dt><dd><div id="alagille.TF.3.2"><p class="no_margin">Heterozygous pathogenic variants in <i>PTPN11</i>, <i>SOS1</i>, <i>RAF1</i>, and <i>RIT1</i> account for 50%, ~10%, 5%, and 5% of Noonan syndrome, respectively. More than 8 genes are known to be associated with Noonan syndrome (see <a href="/books/n/gene/noonan/">Noonan syndrome</a>).</p></div></dd><dt>3. </dt><dd><div id="alagille.TF.3.3"><p class="no_margin">Biallelic pathogenic variants in <i>LZTR1</i> are associated with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> Noonan syndrome (OMIM <a href="https://omim.org/entry/605275" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">605275</a>).</p></div></dd></dl></div></div></div></div><div id="alagille.Management"><h2 id="_alagille_Management_">Management</h2><div id="alagille.Evaluations_Following_Initial_D"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Alagille syndrome (ALGS), the evaluations summarized in <a class="figpopup" href="/books/NBK1273/table/alagille.T.recommended_evaluations_follo/?report=objectonly" target="object" rid-figpopup="figalagilleTrecommendedevaluationsfollo" rid-ob="figobalagilleTrecommendedevaluationsfollo">Table 4</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended.</p><div id="alagille.T.recommended_evaluations_follo" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with Alagille Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1273/table/alagille.T.recommended_evaluations_follo/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__alagille.T.recommended_evaluations_follo_lrgtbl__"><table><thead><tr><th id="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal</b></td><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation by gastroenterologist to incl:
<ul><li class="half_rhythm"><div>Liver function tests</div></li><li class="half_rhythm"><div>Clotting studies</div></li></ul>
</td><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If determined necessary by gastroenterologist, additional studies incl:
<ul><li class="half_rhythm"><div>Serum bile acids</div></li><li class="half_rhythm"><div>Fat-soluble vitamin levels</div></li><li class="half_rhythm"><div>Hepatic ultrasound</div></li><li class="half_rhythm"><div>Technitium-99m-DISIDA scintiscan</div></li><li class="half_rhythm"><div>Liver biopsy</div></li></ul>
</td></tr><tr><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiovascular</b></td><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Complete cardiology evaluation</td><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Incl echocardiogram.</td></tr><tr><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic evaluation</td><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Look for anterior chamber anomalies.</td></tr><tr><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Skeletal</b></td><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AP &#x00026; lateral chest radiographs to evaluate for presence of butterfly vertebrae</td><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Renal</b></td><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluate w/renal function studies &#x00026; renal ultrasound</td><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Growth</b></td><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Measurement of growth parameters &#x00026; plotting on age-appropriate growth charts</td><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Development</b></td><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Screening developmental evaluation</td><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">More detailed evaluation should be performed if significant delays are identified.</td></tr><tr><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other</b></td><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_alagille.T.recommended_evaluations_follo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div></div></div><div id="alagille.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>A multidisciplinary approach to the management of individuals with ALGS is often beneficial because of the multisystem involvement. Evaluation by specialists in clinical genetics, gastroenterology, nutrition, cardiology, ophthalmology, nephrology, transplant hepatology, and child development may be indicated, depending on the age and specific difficulties of the individual [<a class="bk_pop" href="#alagille.REF.kamath.2010.580">Kamath et al 2010</a>].</p><p>Many associated health concerns are treated in a standard manner (cardiovascular abnormality, renal anomalies, vascular accidents) while other findings rarely need intervention (ocular abnormalities) or are only rarely symptomatic (vertebral anomalies).</p><p>A liver specialist familiar with Alagille syndrome is recommended in the treatment of liver manifestations in individuals with this disorder (see <a class="figpopup" href="/books/NBK1273/table/alagille.T.treatment_of_liver_manifestat/?report=objectonly" target="object" rid-figpopup="figalagilleTtreatmentoflivermanifestat" rid-ob="figobalagilleTtreatmentoflivermanifestat">Table 5</a>).</p><div id="alagille.T.treatment_of_liver_manifestat" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Treatment of Liver Manifestations in Individuals with Alagille Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1273/table/alagille.T.treatment_of_liver_manifestat/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__alagille.T.treatment_of_liver_manifestat_lrgtbl__"><table><thead><tr><th id="hd_h_alagille.T.treatment_of_liver_manifestat_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/Concern</th><th id="hd_h_alagille.T.treatment_of_liver_manifestat_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_alagille.T.treatment_of_liver_manifestat_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_alagille.T.treatment_of_liver_manifestat_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pruritus &#x00026; xanthomas</b></td><td headers="hd_h_alagille.T.treatment_of_liver_manifestat_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Choloretic agents (ursodeoxycholic acid) &#x00026; other medications (cholestyramine, rifampin, naltrexone)</td><td headers="hd_h_alagille.T.treatment_of_liver_manifestat_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">A combination of therapies is often required. Biliary diversion may be performed for severe pruritus refractory to medical therapy.</td></tr><tr><td headers="hd_h_alagille.T.treatment_of_liver_manifestat_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>End-stage liver disease</b></td><td headers="hd_h_alagille.T.treatment_of_liver_manifestat_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Liver transplantation</td><td headers="hd_h_alagille.T.treatment_of_liver_manifestat_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_alagille.T.treatment_of_liver_manifestat_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Poor growth</b></td><td headers="hd_h_alagille.T.treatment_of_liver_manifestat_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Optimized nutrition; replacement of fat-soluble vitamins as needed</td><td headers="hd_h_alagille.T.treatment_of_liver_manifestat_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Nasogastric feeds or gastrostomy tube may be required to maintain caloric intake.</td></tr></tbody></table></div></div></div><div id="alagille.Surveillance"><h3>Surveillance</h3><p>Growth should be monitored using standard growth charts so that nutritional intake can be adjusted to need.</p><p>Regular monitoring by a cardiologist, gastroenterologist, and nutritionist is appropriate.</p><p>At this time, the efficacy of presymptomatic screening for vascular anomalies in individuals with ALGS has not been formally evaluated. The possibility of a vascular accident should be considered in any symptomatic individual and MRI, magnetic resonance angiography, and/or angiography to identify aneurysms, dissections, or bleeds should be pursued aggressively as warranted.</p></div><div id="alagille.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Contact sports should be avoided by all individuals, especially those with chronic liver disease, splenomegaly, and vascular involvement.</p><p>Individuals with liver disease should avoid alcohol consumption.</p></div><div id="alagille.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to clarify the genetic status of apparently asymptomatic older and younger at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual in order to identify as early as possible those who would benefit from prompt initiation of treatment and preventive measures.</p><p>Evaluations can include:</p><ul><li class="half_rhythm"><div>Molecular genetic testing if the causative genetic alteration (i.e., a <i>JAG1</i> or <i>NOTCH2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or microdeletion of 20p12) in the family is known;</div></li><li class="half_rhythm"><div>Measurement of liver enzymes, cardiac examination, eye examination, skeletal x-rays, and evaluation of facial features if the <i>JAG1</i> or <i>NOTCH2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is not known.</div></li></ul><p>See <a href="#alagille.Related_Genetic_Counseling_Issu">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="alagille.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Liver and cardiac features should be monitored to ensure that portal hypertension and cardiac dysfunction do not worsen during pregnancy [<a class="bk_pop" href="#alagille.REF.ferrarese.2015.86">Ferrarese et al 2015</a>].</p></div><div id="alagille.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Use of maralixibat, an ileal bile duct transporter inhibitor, is under investigation as a possible treatment for pruritus. Initial results suggest that the drug is safe and may alleviate pruritus in ALGS, although a more thorough investigation of efficacy is necessary [<a class="bk_pop" href="#alagille.REF.shneider.2018.1184">Shneider et al 2018</a>].</p><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="alagille.Genetic_Counseling"><h2 id="_alagille_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="alagille.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Alagille syndrome (ALGS) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="alagille.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div class="half_rhythm">Approximately 30%-50% of individuals diagnosed with ALGS have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div class="half_rhythm">Approximately 50%-70% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have ALGS as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> genetic alteration [<a class="bk_pop" href="#alagille.REF.krantz.1998.1361">Krantz et al 1998</a>, <a class="bk_pop" href="#alagille.REF.crosnier.1999.1141">Crosnier et al 1999</a>, <a class="bk_pop" href="#alagille.REF.spinner.2001.18">Spinner et al 2001</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., an individual with ALGS and no known family history of ALGS) include:</div><ul><li class="half_rhythm"><div>Genetic testing for the causative genetic alteration (i.e., a <i>JAG1</i> or <i>NOTCH2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or 20p12 microdeletion) identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>;</div></li><li class="half_rhythm"><div>Liver function testing, cardiac evaluation, radiographs of the spine, ophthalmologic examination, and evaluation of facial features by a clinical geneticist if the causative genetic alternation has not been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm">If the genetic alteration found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the proband or somatic/<a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent [<a class="bk_pop" href="#alagille.REF.giannakudis.2001.209">Giannakudis et al 2001</a>, <a class="bk_pop" href="#alagille.REF.laufercahana.2002.190">Laufer-Cahana et al 2002</a>].</div><div class="half_rhythm">The frequency of parental somatic/<a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> was approximately 8% in a study of families with <i>JAG1</i>-related ALGS [<a class="bk_pop" href="#alagille.REF.giannakudis.2001.209">Giannakudis et al 2001</a>]. Parents with <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for an ALGS-causing genetic alteration may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a></div></li><li class="half_rhythm"><div class="half_rhythm">The family history of some individuals diagnosed with ALGS may appear to be negative because of failure to recognize the disorder in family members or reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. Therefore, an apparently negative family history cannot be confirmed unless appropriate clinical evaluation and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the clinical/genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or is known to have the genetic alteration identified in the proband, the risk to the sibs is 50%. Significant <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a> is observed in ALGS; the clinical manifestations in <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> sibs cannot be predicted and may range from mild or subclinical features to severe heart and/or liver disease.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a known ALGS-related genetic alteration that cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is greater than that of the general population because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#alagille.REF.giannakudis.2001.209">Giannakudis et al 2001</a>, <a class="bk_pop" href="#alagille.REF.laufercahana.2002.190">Laufer-Cahana et al 2002</a>].</div></li><li class="half_rhythm"><div>If the parents have not been tested for the ALGS-related genetic alteration but are clinically unaffected, sibs are still presumed to be at increased risk for ALGS because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> parent or parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>. Multiple instances of a child inheriting ALGS from an apparently unaffected, phenotypically normal parent who was mosaic for a 20p microdeletion have been reported [<a class="bk_pop" href="#alagille.REF.giannakudis.2001.209">Giannakudis et al 2001</a>, <a class="bk_pop" href="#alagille.REF.laufercahana.2002.190">Laufer-Cahana et al 2002</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Offspring of an individual with ALGS have a 50% chance of inheriting the ALGS-related genetic alteration. The clinical manifestations in <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> offspring cannot be predicted and range from mild or subclinical features to severe heart and/or liver disease.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>/has the ALGS-related genetic alteration, his or her family members are at risk.</p></div><div id="alagille.Related_Genetic_Counseling_Issu"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#alagille.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a></b>. When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="alagille.Prenatal_Testing_and_Preimplant"><h3>Prenatal Testing and Preimplantation Genetic Testing</h3><p><b>Molecular genetic testing.</b> Once the causative genetic alteration (i.e., a <i>JAG1</i> or <i>NOTCH2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or a <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 20p12 structural variant) has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-testing/">preimplantation genetic testing</a> are possible. Note: Because <i>JAG1</i>- and <i>NOTCH2</i>-related ALGS demonstrate highly <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> with clinical features ranging from subclinical to severe, clinical manifestations cannot be predicted by molecular genetic prenatal testing.</p><p><b>Fetal ultrasound examination.</b> In fetuses at 50% risk for ALGS, fetal echocardiogram may detect a significant structural defect of the heart; however, a normal fetal echocardiogram does not eliminate the possibility of ALGS or the possibility of a structural cardiac abnormality in the fetus.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="alagille.Resources"><h2 id="_alagille_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Alagille Syndrome Alliance</b></div><div>10500 Southwest Starr Drive</div><div>Tualatin OR 97062</div><div><b>Phone:</b> 503-885-0455</div><div><b>Email:</b> alagille@alagille.org</div><div><a href="http://www.alagille.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.alagille.org</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=alagillesyndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Alagille syndrome</a></div></li><li class="half_rhythm"><div><b>American Liver Foundation</b></div><div>75 Maiden Lane</div><div>Suite 603</div><div>New York NY 10038</div><div><b>Phone:</b> 800-465-4837 (Toll-free HelpLine); 212-668-1000</div><div><b>Fax:</b> 212-483-8179</div><div><b>Email:</b> info@liverfoundation.org</div><div><a href="http://www.liverfoundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.liverfoundation.org</a></div></li><li class="half_rhythm"><div><b>Canadian Liver Foundation (CLF)</b></div><div>2235 Sheppard Avenue East</div><div>Suite 1500</div><div>Toronto Ontario M2J 5B5</div><div>Canada</div><div><b>Phone:</b> 800-563-5483 (toll-free); 416-491-3353</div><div><b>Fax:</b> 416-491-4952</div><div><b>Email:</b> clf@liver.ca</div><div><a href="http://www.liver.ca" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.liver.ca</a></div></li><li class="half_rhythm"><div><b>Childhood Liver Disease Research and Education Network (ChiLDREN)</b></div><div><b>Phone:</b> 720-777-2598</div><div><b>Email:</b> joan.hines@childrenscolorado.org</div><div><a href="https://childrennetwork.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.childrennetwork.org</a></div></li><li class="half_rhythm"><div><b>Children's Liver Disease Foundation (CLDF)</b></div><div>36 Great Charles Street</div><div> Birmingham B3 3JY</div><div>United Kingdom</div><div><b>Phone:</b> +44 (0) 121 212 3839</div><div><b>Fax:</b> +44 (0) 121 212 4300</div><div><b>Email:</b> info@childliverdisease.org</div><div><a href="http://www.childliverdisease.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.childliverdisease.org</a></div></li></ul></div><div id="alagille.Molecular_Genetics"><h2 id="_alagille_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="alagille.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Alagille Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1273/table/alagille.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__alagille.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_alagille.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_alagille.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_alagille.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_alagille.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_alagille.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_alagille.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_alagille.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/182" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>JAG1</i></a></td><td headers="hd_b_alagille.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=182" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">20p12<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_alagille.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P78504" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Protein jagged-1</a></td><td headers="hd_b_alagille.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://research.cchmc.org/LOVD2/home.php?select_db=JAG1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CCHMC - Human Genetics Mutation Database (JAG1)</a><br /><a href="https://databases.lovd.nl/shared/genes/JAG1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">JAG1 @ LOVD</a></td><td headers="hd_b_alagille.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=JAG1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">JAG1</a></td><td headers="hd_b_alagille.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=JAG1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">JAG1</a></td></tr><tr><td headers="hd_b_alagille.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4853" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>NOTCH2</i></a></td><td headers="hd_b_alagille.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4853" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1p12</a></td><td headers="hd_b_alagille.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q04721" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Neurogenic locus notch homolog protein 2</a></td><td headers="hd_b_alagille.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/NOTCH2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NOTCH @LOVD</a></td><td headers="hd_b_alagille.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=NOTCH2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NOTCH2</a></td><td headers="hd_b_alagille.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NOTCH2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NOTCH2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="alagille.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="alagille.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Alagille Syndrome (<a href="/omim/118450,600275,601920,610205" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1273/table/alagille.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__alagille.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/118450" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">118450</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ALAGILLE SYNDROME 1; ALGS1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600275" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600275</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NOTCH, DROSOPHILA, HOMOLOG OF, 2; NOTCH2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601920" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601920</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">JAGGED 1; JAG1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/610205" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">610205</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ALAGILLE SYNDROME 2; ALGS2</td></tr></tbody></table></div></div><div id="alagille.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p><b>Introduction.</b>
<i>JAG1</i> and <i>NOTCH2</i> encode for a ligand and a receptor protein, respectively, involved in the Notch signaling pathway. Notch signaling is highly ubiquitous, with defects resulting in a variety of human diseases. The name "Notch" derives from the characteristic notched wing found in fruit flies carrying only one functional copy of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. Homozygous pathogenic variants in <i>Notch</i> in fruit flies are lethal, and the flies show hypertrophy of the nervous system. The finding that pathogenic variants in <i>JAG1</i> cause ALGS indicates that Notch signaling is important in the development of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> organs (i.e., liver, heart, kidney, facial structures, skeleton, and eye).</p><p>The JAG1 and NOTCH2 proteins are both single-pass, transmembrane proteins. Binding of the extracellular region of JAG1 to the extracellular region of NOTCH2 prompts cleavage of the intracellular <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of NOTCH2, which translocates to the nucleus to regulate the expression of Notch signaling target genes, including those belonging to the <i>HES</i> and <i>HEY</i> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> families.</p><p>During cholangiocyte specification, mesenchymal cells surrounding the portal vein express JAG1 while the hepatocytes express NOTCH2, and mouse studies have demonstrated a requirement of Notch signaling for liver development.</p><p><b>Mechanism of disease causation.</b> The disease mechanism of ALGS is <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>, and the majority of disease-associated <i>JAG1</i> variants (~87%) are <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants. Many <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in <i>JAG1</i>, particularly those that involve loss of a cysteine, result in proteins that are unable to signal with NOTCH2 and/or are improperly trafficked and not expressed on the cell membrane.</p><p><i>NOTCH2</i> variants are predominantly <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> and the pathogenicity of these variants is less understood.</p><div id="alagille.T.alagille_syndrome_genespecifi" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Alagille Syndrome: Gene-Specific Laboratory Considerations</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1273/table/alagille.T.alagille_syndrome_genespecifi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__alagille.T.alagille_syndrome_genespecifi_lrgtbl__"><table><thead><tr><th id="hd_h_alagille.T.alagille_syndrome_genespecifi_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_alagille.T.alagille_syndrome_genespecifi_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Special Consideration</th></tr></thead><tbody><tr><td headers="hd_h_alagille.T.alagille_syndrome_genespecifi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NOTCH2</i></td><td headers="hd_h_alagille.T.alagille_syndrome_genespecifi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NOTCH2NLR</i>, a <a class="def" href="/books/n/gene/glossary/def-item/pseudogene/">pseudogene</a> containing 5 exons &#x02013; the first 4 corresponding to the first 4 exons of <i>NOTCH2</i> &#x00026; the 5th corresponding to an <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> region of <i>NOTCH2</i> &#x02013; interferes w/analysis of <i>NOTCH2</i>.</td></tr></tbody></table></div></div><div id="alagille.T.alagille_syndrome_notable_pat" class="table"><h3><span class="label">Table 7. </span></h3><div class="caption"><p>Alagille Syndrome: Notable Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1273/table/alagille.T.alagille_syndrome_notable_pat/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__alagille.T.alagille_syndrome_notable_pat_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_alagille.T.alagille_syndrome_notable_pat_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_alagille.T.alagille_syndrome_notable_pat_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference<br />Sequences</th><th id="hd_h_alagille.T.alagille_syndrome_notable_pat_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_alagille.T.alagille_syndrome_notable_pat_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_alagille.T.alagille_syndrome_notable_pat_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_alagille.T.alagille_syndrome_notable_pat_1_1_1_1" rowspan="5" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>JAG1</i></td><td headers="hd_h_alagille.T.alagille_syndrome_notable_pat_1_1_1_2" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000214.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000214<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_000205.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000205<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_h_alagille.T.alagille_syndrome_notable_pat_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.551G&#x0003e;A</td><td headers="hd_h_alagille.T.alagille_syndrome_notable_pat_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg184His</td><td headers="hd_h_alagille.T.alagille_syndrome_notable_pat_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">A common <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant</td></tr><tr><td headers="hd_h_alagille.T.alagille_syndrome_notable_pat_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.232T&#x0003e;C</td><td headers="hd_h_alagille.T.alagille_syndrome_notable_pat_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys78Arg</td><td headers="hd_h_alagille.T.alagille_syndrome_notable_pat_1_1_1_5" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;">An example of a cysteine residue<br />critical for protein function</td></tr><tr><td headers="hd_h_alagille.T.alagille_syndrome_notable_pat_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:top;">c.232T&#x0003e;G</td><td headers="hd_h_alagille.T.alagille_syndrome_notable_pat_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">p.Cys78Gly</td></tr><tr><td headers="hd_h_alagille.T.alagille_syndrome_notable_pat_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:top;">c.233G&#x0003e;C</td><td headers="hd_h_alagille.T.alagille_syndrome_notable_pat_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">p.Cys78Ser</td></tr><tr><td headers="hd_h_alagille.T.alagille_syndrome_notable_pat_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:top;">c.233G&#x0003e;A</td><td headers="hd_h_alagille.T.alagille_syndrome_notable_pat_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">p.Cys78Tyr</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div></div><div id="alagille.Cancer_and_Benign_Tumors"><h3>Cancer and Benign Tumors</h3><p>Somatic variants in <i>NOTCH2</i> have been reported in 10%-20% of splenic marginal zone lymphomas (SMZL). <i>NOTCH2</i> somatic variants were found to cluster in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 34, which encodes the C-terminal PEST <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, which is necessary for regulation of the intracellular domain and downstream regulation of transcription [<a class="bk_pop" href="#alagille.REF.jaramillo_oquendo.2019.10444">Jaramillo Oquendo et al 2019</a>].</p></div></div><div id="alagille.References"><h2 id="_alagille_References_">References</h2><div id="alagille.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.adams.2019">Adams JM, Huppert KA, Castro EC, Lopez MF, Niknejad N, Subramanian S, Zarrin-Khameh N, Finegold MJ, Huppert SS, Jafar-Nejad H. Sox9 is a modifier of the liver disease severity in a mouse model of Alagille syndrome. <span><span class="ref-journal">Hepatology. </span>2019.</span> Epub ahead of print. [<a href="/pubmed/31469182" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 31469182</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.arvay.2005.146">Arvay JL, Zemel BS, Gallagher PR, Rovner AJ, Mulberg AE, Stallings VA, Haber BA. Body composition of children aged 1 to 12 years with biliary atresia or Alagille syndrome. <span><span class="ref-journal">J Pediatr Gastroenterol Nutr. </span>2005;<span class="ref-vol">40</span>:146–50.</span> [<a href="/pubmed/15699687" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15699687</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.bauer.2010.594">Bauer RC, Laney AO, Smith R, Gerfen J, Morrissette JJ, Woyciechowski S, Garvarini J, Loomes KM, Krantz ID, Urban Z, Gelb BD, Goldmuntz E, Spinner NB. Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis. <span><span class="ref-journal">Hum Mutat. </span>2010;<span class="ref-vol">31</span>:594–601.</span> [<a href="/pmc/articles/PMC2914103/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2914103</span></a>] [<a href="/pubmed/20437614" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20437614</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.cho.2015.552">Cho JM, Oh SH, Kim HJ, Kim JS, Kim KM, Kim GH, Yu E, Lee BH, Yoo HW. Clinical features, outcomes, and genetic analysis in Korean children with Alagille syndrome. <span><span class="ref-journal">Pediatr Int. </span>2015;<span class="ref-vol">57</span>:552–7.</span> [<a href="/pubmed/25676721" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25676721</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.crosnier.1999.1141">Crosnier C, Driancourt C, Raynaud N, Dhorne-Pollet S, Pollet N, Bernard O, Hadchouel M, Meunier-Rotival M. Mutations in JAGGED1 gene are predominantly sporadic in Alagille syndrome. <span><span class="ref-journal">Gastroenterology. </span>1999;<span class="ref-vol">116</span>:1141–8.</span> [<a href="/pubmed/10220506" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10220506</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.eldadah.2001.163">Eldadah ZA, Hamosh A, Biery NJ, Montgomery RA, Duke M, Elkins R, Dietz HC. Familial Tetralogy of Fallot caused by mutation in the jagged1 gene. <span><span class="ref-journal">Hum Mol Genet. </span>2001;<span class="ref-vol">10</span>:163–9.</span> [<a href="/pubmed/11152664" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11152664</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.elkoofy.2011.199">El-Koofy NM, El-Mahdy R, Fahmy ME, El-Hennawy A, Farag MY, El-Karaksy HM. Alagille syndrome: clinical and ocular pathognomonic features. <span><span class="ref-journal">Eur J Ophthalmol. </span>2011;<span class="ref-vol">21</span>:199–206.</span> [<a href="/pubmed/20677167" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20677167</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.emerick.2005.99">Emerick KM, Krantz ID, Kamath BM, Darling C, Burrowes DM, Spinner NB, Whitington PF, Piccoli DA. Intracranial vascular abnormalities in patients with Alagille syndrome. <span><span class="ref-journal">J Pediatr Gastroenterol Nutr. </span>2005;<span class="ref-vol">41</span>:99–107.</span> [<a href="/pubmed/15990638" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15990638</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.emerick.1999.822">Emerick KM, Rand EB, Goldmuntz E, Krantz ID, Spinner NB, Piccoli DA. Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. <span><span class="ref-journal">Hepatology. </span>1999;<span class="ref-vol">29</span>:822–9.</span> [<a href="/pubmed/10051485" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10051485</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.ferrarese.2015.86">Ferrarese A, Senzolo M, Burra P. Successful pregnancy in Alagille syndrome. <span><span class="ref-journal">Dig Liver Dis. </span>2015;<span class="ref-vol">47</span>:86–7.</span> [<a href="/pubmed/25260494" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25260494</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.giannakudis.2001.209">Giannakudis J, R&#x000f6;pke A, Kujat A, Krajewska-Walasek M, Hughes H, Fryns JP, Bankier A, Amor D, Schlicker M, Hansmann I. Parental mosaicism of JAG1 mutations in families with Alagille syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2001;<span class="ref-vol">9</span>:209–16.</span> [<a href="/pubmed/11313761" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11313761</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.gilbert.2019.2197">Gilbert MA, Bauer RC, Rajagopalan R, Grochowski CM, Chao G, McEldrew D, Nassur JA, Rand EB, Krock BL, Kamath BM, Krantz ID, Piccoli DA, Loomes KM, Spinner NB. Alagille syndrome mutation update: comprehensive overview of JAG1 and NOTCH2 mutation frequencies and insight into missense variant classification. <span><span class="ref-journal">Hum Mutat. </span>2019;<span class="ref-vol">40</span>:2197–220.</span> [<a href="/pmc/articles/PMC6899717/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6899717</span></a>] [<a href="/pubmed/31343788" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 31343788</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.guegan.2012.33">Guegan K, Stals K, Day M, Turnpenny P, Ellard S. JAG1 mutations are found in approximately one third of patients presenting with only one or two clinical features of Alagille syndrome. <span><span class="ref-journal">Clin Genet. </span>2012;<span class="ref-vol">82</span>:33–40.</span> [<a href="/pubmed/21752016" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21752016</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.gurkan.1999.416">Gurkan A, Emre S, Fishbein TM, Brady L, Millis M, Birnbaum A, Kim-Schluger L, Sheiner PA. Unsuspected bile duct paucity in donors for living-related liver transplantation: two case reports. <span><span class="ref-journal">Transplantation. </span>1999;<span class="ref-vol">67</span>:416–8.</span> [<a href="/pubmed/10030288" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10030288</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.hingorani.1999.330">Hingorani M, Nischal KK, Davies A, Bentley C, Vivian A, Baker AJ, Mieli-Vergani G, Bird AC, Aclimandos WA. Ocular abnormalities in Alagille syndrome. <span><span class="ref-journal">Ophthalmology. </span>1999;<span class="ref-vol">106</span>:330–7.</span> [<a href="/pubmed/9951486" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9951486</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.jaramillo_oquendo.2019.10444">Jaramillo Oquendo C, Parker H, Oscier D, Ennis S, Gibson J, Strefford JC. Systematic review of somatic mutations in splenic marginal zone lymphoma. <span><span class="ref-journal">Sci Rep. </span>2019;<span class="ref-vol">9</span>:10444.</span> [<a href="/pmc/articles/PMC6639539/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6639539</span></a>] [<a href="/pubmed/31320741" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 31320741</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.kamath.2003.891">Kamath BM, Bason L, Piccoli DA, Krantz ID, Spinner NB. Consequences of JAG1 mutations. <span><span class="ref-journal">J Med Genet. </span>2003;<span class="ref-vol">40</span>:891–5.</span> [<a href="/pmc/articles/PMC1735339/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735339</span></a>] [<a href="/pubmed/14684686" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14684686</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.kamath.2012a.138">Kamath BM, Baur RC, Loomes KM, Chao G, Gerfen J, Hutchinson A, Hardikar W, Hirschfield G, Jara P, Krantz ID, Lapunzina P, Leonard L, Ling S, Ng VL, Hoang PL, Piccoli DA, Spinner NB. NOTCH2 mutations in Alagille syndrome. <span><span class="ref-journal">J Med Genet. </span>2012a;<span class="ref-vol">49</span>:138–44.</span> [<a href="/pmc/articles/PMC3682659/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3682659</span></a>] [<a href="/pubmed/22209762" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22209762</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.kamath.2015.390">Kamath BM, Chen Z, Romero R, Fredericks EM, Alonso EM, Arnon R, Heubi J, Hertel PM, Karpen SJ, Loomes KM, Murray KF, Rosenthal P, Schwarz KB, Subbarao G, Teckman JH, Turmelle YP, Wang KS, Sherker AH, Sokol RJ, Magee JC, et al.  Quality of life and its determinants in a multicenter cohort of children with Alagille syndrome. <span><span class="ref-journal">J Pediatr. </span>2015;<span class="ref-vol">167</span>:390–6.e3.</span> [<a href="/pmc/articles/PMC4516587/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4516587</span></a>] [<a href="/pubmed/26059338" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26059338</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.kamath.2010.580">Kamath BM, Loomes KM, Piccoli DA. Medical management of Alagille syndrome. <span><span class="ref-journal">J Pediatr Gastroenterol Nutr. </span>2010;<span class="ref-vol">50</span>:580–6.</span> [<a href="/pubmed/20479679" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20479679</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.kamath.2012b.85">Kamath BM, Podkameni G, Hutchinson AL, Leonard LD, Gerfen J, Krantz ID, Piccoli DA, Spinner NB, Loomes KM, Meyers K. Renal anomalies in Alagille syndrome: A disease-defining feature. <span><span class="ref-journal">Am J Med Genet Part A. </span>2012b;<span class="ref-vol">158A</span>:85–9.</span> [<a href="/pmc/articles/PMC4511708/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4511708</span></a>] [<a href="/pubmed/22105858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22105858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.kamath.2004.1354">Kamath BM, Spinner NB, Emerick KM, Chudley AE, Booth C, Piccoli DA, Krantz ID. Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. <span><span class="ref-journal">Circulation. </span>2004;<span class="ref-vol">109</span>:1354–8.</span> [<a href="/pubmed/14993126" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14993126</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.kamath.2002.176">Kamath BM, Stolle C, Bason L, Colliton RP, Piccoli DA, Spinner NB, Krantz ID. Craniosynostosis in Alagille syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">112</span>:176–80.</span> [<a href="/pubmed/12244552" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12244552</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.kamath.2009.371">Kamath BM, Thiel BD, Gai X, Conlin LK, Munoz PS, Glessner J, Clark D, Warthen DM, Shaikh TH, Mihci E, Piccoli DA, Grant SF, Hakonarson H, Krantz ID, Spinner NB. SNP array mapping of chromosome 20p deletions: genotypes, phenotypes, and copy number variation. <span><span class="ref-journal">Hum Mutat. </span>2009;<span class="ref-vol">30</span>:371–8.</span> [<a href="/pmc/articles/PMC2650004/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2650004</span></a>] [<a href="/pubmed/19058200" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19058200</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.kamath.2012c.940">Kamath BM, Yin W, Miller H, Anand R, Rand EB, Alonso E, Bucuvalas J, et al.  Outcomes of liver transplantation for patients with Alagille syndrome: the studies of pediatric liver transplantation experience. <span><span class="ref-journal">Liver Transpl. </span>2012c;<span class="ref-vol">18</span>:940–8.</span> [<a href="/pubmed/22454296" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22454296</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.kiel.2012.1553">Kiel MJ, Velusamy T, Betz BL, Zhao L, Weigelin HG, Chiang MY, Huebner-Chan DR, Bailey NG, Yang DT, Bhagat G, Miranda RN, Bahler DW, Medeiros LJ, Lim MS, Elenitoba-Johnson KS. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. <span><span class="ref-journal">J Exp Med. </span>2012;<span class="ref-vol">209</span>:1553–65.</span> [<a href="/pmc/articles/PMC3428949/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3428949</span></a>] [<a href="/pubmed/22891276" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22891276</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.krantz.1998.1361">Krantz ID, Colliton RP, Genin A, Rand EB, Li L, Piccoli DA, Spinner NB. Spectrum and frequency of jagged1 (JAG1) mutations in Alagille syndrome patients and their families. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">62</span>:1361–9.</span> [<a href="/pmc/articles/PMC1377154/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377154</span></a>] [<a href="/pubmed/9585603" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9585603</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.krantz.1999.56">Krantz ID, Smith R, Colliton RP, Tinkel H, Zackai EH, Piccoli DA, Goldmuntz E, Spinner NB. Jagged1 mutations in patients ascertained with isolated congenital heart defects. <span><span class="ref-journal">Am J Med Genet. </span>1999;<span class="ref-vol">84</span>:56–60.</span> [<a href="/pubmed/10213047" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10213047</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.laufercahana.2002.190">Laufer-Cahana A, Krantz ID, Bason LD, Lu FM, Piccoli DA, Spinner NB. Alagille syndrome inherited from a phenotypically normal mother with a mosaic 20p microdeletion. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">112</span>:190–3.</span> [<a href="/pubmed/12244554" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12244554</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.lin.2012.1005">Lin HC, Hoang PL, Hutchinson A, Chao G, Gerfen J, Loomes KM, Krantz ID, Kamath BM, Spinner NB. Alagille syndrome in a Vietnamese cohort: Mutation analysis and assessment of facial features. <span><span class="ref-journal">Am J Med Genet Part A. </span>2012;<span class="ref-vol">158A</span>:1005–13.</span> [<a href="/pmc/articles/PMC3331947/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3331947</span></a>] [<a href="/pubmed/22488849" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22488849</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.loomes.2019.245">Loomes KM, Spino C, Goodrich NP, Hangartner TN, Marker AE, Heubi JE, Kamath BM, Shneider BL, Rosenthal P, Hertel PM, Karpen SJ, Molleston JP, Murray KF, Schwarz KB, Squires RH, Teckman J, Turmelle YP, Alonso EM, Sherker AH, Magee JC, Sokol RJ, et al.  Bone density in children with chronic liver disease correlates with growth and cholestasis. <span><span class="ref-journal">Hepatology. </span>2019;<span class="ref-vol">69</span>:245–57.</span> [<a href="/pmc/articles/PMC6324969/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6324969</span></a>] [<a href="/pubmed/30063078" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30063078</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.lykavieris.2001.431">Lykavieris P, Hadchouel M, Chardot C, Bernard O. Outcome of liver disease in children with Alagille syndrome: a study of 163 patients. <span><span class="ref-journal">Gut. </span>2001;<span class="ref-vol">49</span>:431–5.</span> [<a href="/pmc/articles/PMC1728437/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1728437</span></a>] [<a href="/pubmed/11511567" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11511567</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.makino.2012.1445">Makino S, Ohkubo Y, Tampo H. Optical coherence tomography and fundus autofluorescence imaging study of chorioretinal atrophy involving the macula in Alagille syndrome. <span><span class="ref-journal">Clin Ophthalmol. </span>2012;<span class="ref-vol">6</span>:1445–8.</span> [<a href="/pmc/articles/PMC3460705/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3460705</span></a>] [<a href="/pubmed/23055661" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23055661</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.mcelhinney.2002.2567">McElhinney DB, Krantz ID, Bason L, Piccoli DA, Emerick KM, Spinner NB, Goldmuntz E. Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. <span><span class="ref-journal">Circulation. </span>2002;<span class="ref-vol">106</span>:2567–74.</span> [<a href="/pubmed/12427653" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12427653</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.mitchell.2018.625">Mitchell E, Gilbert M, Loomes KM. Alagille syndrome. <span><span class="ref-journal">Clin Liver Dis. </span>2018;<span class="ref-vol">22</span>:625–41.</span> [<a href="/pubmed/30266153" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30266153</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.mouzaki.2016.755">Mouzaki M, Bass LM, Sokol RJ, Piccoli DA, Quammie C, Loomes KM, Heubi JE, Hertel PM, Scheenstra R, Furuya K, Kutsch E, Spinner NB, Robbins KN, Venkat V, Rosenthal P, Beyene J, Baker A, Kamath BM. Early life predictive markers of liver disease outcome in an international, multicentre cohort of children with Alagille syndrome. <span><span class="ref-journal">Liver Int. </span>2016;<span class="ref-vol">36</span>:755–60.</span> [<a href="/pmc/articles/PMC5401769/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5401769</span></a>] [<a href="/pubmed/26201540" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26201540</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.mouzaki.2010.1006">Mouzaki M, Nichter C, Qureshi M, Rountree B, Furuya KN. Idiopathic intracranial hypertension in two patients with Alagille syndrome. <span><span class="ref-journal">J Child Neurol. </span>2010;<span class="ref-vol">25</span>:1006–8.</span> [<a href="/pubmed/20501886" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20501886</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.narula.2006.348">Narula P, Gifford J, Steggall MA, Lloyd C, Van Mourik ID, Mckiernan PJ, Willshaw HE, Kelly D. Visual loss and idiopathic intracranial hypertension in children with Alagille syndrome. <span><span class="ref-journal">J Pediatr Gastroenterol Nutr. </span>2006;<span class="ref-vol">43</span>:348–52.</span> [<a href="/pubmed/16954958" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16954958</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.rauch.2010.321">Rauch R, Hofbeck M, Zweier C, Koch A, Zink S, Trautmann U, Hoyer J, Kaulitz R, Singer H, Rauch A. omprehensive genotypey-phenotype analysis in 230 patients with tetralogy of Fallot. <span><span class="ref-journal">J Med Genet. </span>2010;<span class="ref-vol">47</span>:321–31.</span> [<a href="/pubmed/19948535" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19948535</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.rocha.2012.125">Rocha R, Soro I, Leit&#x000e3;o A, Silva ML, Le&#x000e3;o M. Moyamoya vascular pattern in Alagille syndrome. <span><span class="ref-journal">Pediatr Neurol. </span>2012;<span class="ref-vol">47</span>:125–8.</span> [<a href="/pubmed/22759690" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22759690</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.romero.2018">Romero R. The renal sequelae of Alagille Syndrome as a Product of Altered Notch Signaling During Kidney Development. In: Kamath, BM and Loomes, KM, eds. <em>Alagille Syndrome: Pathogenesis and Clinical Management</em>. Cham, Switzerland: Springer Nature Switzerland AG; 2018:103-20.</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.saleh.2016.75">Saleh M, Kamath BM, Chitayat D. Alagille syndrome: clinical perspectives. <span><span class="ref-journal">Appl Clin Genet. </span>2016;<span class="ref-vol">9</span>:75–82.</span> [<a href="/pmc/articles/PMC4935120/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4935120</span></a>] [<a href="/pubmed/27418850" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27418850</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.salem.2012.1300">Salem JE, Bruguiere E, Iserin L, Guiochon-Mantel A, Plouin PF. Hypertension and aortorenal disease in Alagille syndrome. <span><span class="ref-journal">J Hypertens. </span>2012;<span class="ref-vol">30</span>:1300–6.</span> [<a href="/pubmed/22525199" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22525199</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.sanderson.2002.114">Sanderson E, Newman V, Haigh SF, Baker A, Sidhu PS. Vertebral anomalies in children with Alagille syndrome: an analysis of 50 consecutive patients. <span><span class="ref-journal">Pediatr Radiol. </span>2002;<span class="ref-vol">32</span>:114–9.</span> [<a href="/pubmed/11819079" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11819079</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.shneider.2018.1184">Shneider BL, Spino C, Kamath BM, Magee JC, Bass LM, Setchell KD, Miethke A, Molleston JP, Mack CL, Squires RH, Murray KF, Loomes KM, Rosenthal P, Karpen SJ, Leung DH, Guthery SL, Thomas D, Sherker AH, Sokol RJ. Placebo-controlled randomized trial of an intestinal bile salt transport inhibitor for pruritus in Alagille syndrome. <span><span class="ref-journal">Hepatol Commun. </span>2018;<span class="ref-vol">2</span>:1184–98.</span> [<a href="/pmc/articles/PMC6167076/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6167076</span></a>] [<a href="/pubmed/30288474" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30288474</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.spinner.2001.18">Spinner NB, Colliton RP, Crosnier C, Krantz ID, Hadchouel M, Meunier-Rotival M. Jagged1 mutations in Alagille syndrome. <span><span class="ref-journal">Hum Mutat. </span>2001;<span class="ref-vol">17</span>:18–33.</span> [<a href="/pubmed/11139239" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11139239</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.subramaniam.2011.84">Subramaniam P, Knisely A, Portmann B, Qureshi SA, Aclimandos WA, Karani JB, Baker AJ. Diagnosis of Alagille syndrome-25 years of experience at King's College Hospital. <span><span class="ref-journal">J Pediatr Gastroenterol Nutr. </span>2011;<span class="ref-vol">52</span>:84–9.</span> [<a href="/pubmed/21119543" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21119543</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.thakurdas.2016.550">Thakurdas SM, Lopez MF, Kakuda S, Fernandez-Valdivia R, Zarrin-Khameh N, Haltiwanger RS, Jafar-Nejad H. Jagged1 heterozygosity in mice results in a congenital cholangiopathy which is reversed by concomitant deletion of one copy of Poglut1 (Rumi). <span><span class="ref-journal">Hepatology. </span>2016;<span class="ref-vol">63</span>:550–65.</span> [<a href="/pmc/articles/PMC4718747/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4718747</span></a>] [<a href="/pubmed/26235536" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26235536</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.tretter.2018">Tretter JT, McElhinney DB. Cardiac, aortic, and pulmonary vascular involvement in Alagille syndrome. In: Kamath, BM and Loomes, KM, eds. <em>Alagille Syndrome: Pathogenesis and Clinical Management</em>. Cham, Switzerland: Springer Nature Switzerland AG; 2018:77-90.</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.tsai.2016.663">Tsai EA, Gilbert MA, Grochowski CM, Underkoffler LA, Meng H, Zhang X, Wang MM, Shitaye H, Hankenson KD, Piccoli D, Lin H, Kamath BM, Devoto M, Spinner NB, Loomes KM. THBS2 is a candidate modifier of liver disease severity in Alagille syndrome. <span><span class="ref-journal">Cell Mol Gastroenterol Hepatol. </span>2016;<span class="ref-vol">2</span>:663–75.e2.</span> [<a href="/pmc/articles/PMC5042888/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5042888</span></a>] [<a href="/pubmed/28090565" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28090565</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.turnpenny.2012.251">Turnpenny PD, Ellard S. Alagille syndrome: pathogenesis, diagnosis and management. <span><span class="ref-journal">Eur J Hum Genet. </span>2012;<span class="ref-vol">20</span>:251–7.</span> [<a href="/pmc/articles/PMC3283172/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3283172</span></a>] [<a href="/pubmed/21934706" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21934706</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.woolfenden.1999.505">Woolfenden AR, Albers GW, Steinberg GK, Hahn JS, Johnston DCC, Farrell K. Moyamoya syndrome in children with Alagille syndrome: additional evidence of a vasculopathy. <span><span class="ref-journal">Pediatrics. </span>1999;<span class="ref-vol">103</span>:505–8.</span> [<a href="/pubmed/9925853" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9925853</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.yilmaz.2013.146">Yilmaz S, Turhan T, Mutluer S, Aydogdu S. The association of Alagille syndrome and craniosynostosis. <span><span class="ref-journal">Pediatr Neurol. </span>2013;<span class="ref-vol">48</span>:146–8.</span> [<a href="/pubmed/23337010" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23337010</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="alagille.REF.zanotti.2010.886">Zanotti S, Canalis E. Notch and the skeleton. <span><span class="ref-journal">Mol Cell Biol. </span>2010;<span class="ref-vol">30</span>:886–96.</span> [<a href="/pmc/articles/PMC2815558/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2815558</span></a>] [<a href="/pubmed/19995916" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19995916</span></a>]</div></li></ul></div></div><div id="alagille.Chapter_Notes"><h2 id="_alagille_Chapter_Notes_">Chapter Notes</h2><div id="alagille.Author_History"><h3>Author History</h3><p>Lynn D Bason, MS, CGC; Children's Hospital of Philadelphia (2000-2003) <br />Melissa A Gilbert, PhD (2019-present)<br />Anne L Hutchinson, BS; Children's Hospital of Philadelphia (2010-2013)<br />Binita M Kamath, MBBChir MRCP; The Hospital for Sick Children (2003-2013) <br />Ian D Krantz, MD (2000-present) <br />Laura D Leonard, BA; Children's Hospital of Philadelphia (2013-2019)<br />Kathleen M Loomes, MD (2019-present)<br />Nancy B Spinner, PhD (2000-present)</p></div><div id="alagille.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>12 December 2019 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>28 February 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>20 July 2010 (cd) Revision: prenatal testing available for <i>NOTCH2</i> mutations</div></li><li class="half_rhythm"><div>11 May 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>2 July 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>18 May 2006 (cd) Revision: <i>NOTCH2</i> mutations identified in individuals with Alagille syndrome</div></li><li class="half_rhythm"><div>18 February 2005 (mr) Comprehensive update posted live</div></li><li class="half_rhythm"><div>2 February 2004 (ns) Author revisions</div></li><li class="half_rhythm"><div>16 June 2003 (cd) Revision: DNA and RNA <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> available on clinical basis</div></li><li class="half_rhythm"><div>4 February 2003 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>19 May 2000 (me) Review posted live</div></li><li class="half_rhythm"><div>January 2000 (ns) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1273</span><span class="label">PMID: <a href="/pubmed/20301450" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301450</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ags/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/alexander/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1273&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1273/?report=reader">PubReader</a></li><li><a href="/books/NBK1273/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1273" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1273" style="display:none" title="Cite this Page"><div class="bk_tt">Spinner NB, Gilbert MA, Loomes KM, et al. Alagille Syndrome. 2000 May 19 [Updated 2019 Dec 12]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1273/pdf/Bookshelf_NBK1273.pdf">PDF version of this page</a> (523K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#alagille.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#alagille.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#alagille.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#alagille.Genetically_Related_Allelic_Dis" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#alagille.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#alagille.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#alagille.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#alagille.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#alagille.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#alagille.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#alagille.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4853[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">NOTCH2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=182[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">JAG1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1273+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1460506" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1460506" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1460506" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1460506" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29939604" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Alagille Syndrome</a><span class="source">[StatPearls. 2019]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Alagille Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Diaz-Frias J, Kondamudi NP. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">StatPearls. 2019 Jan</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21934706" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Alagille syndrome: pathogenesis, diagnosis and management.</a><span class="source">[Eur J Hum Genet. 2012]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Alagille syndrome: pathogenesis, diagnosis and management.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Turnpenny PD, Ellard S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Hum Genet. 2012 Mar; 20(3):251-7. Epub 2011 Sep 21.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27418850" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Alagille syndrome: clinical perspectives.</a><span class="source">[Appl Clin Genet. 2016]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Alagille syndrome: clinical perspectives.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Saleh M, Kamath BM, Chitayat D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Appl Clin Genet. 2016; 9:75-82. Epub 2016 Jun 30.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30828556" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Alagille Syndrome and the Liver: Current Insights.</a><span class="source">[Euroasian J Hepatogastroentero...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Alagille Syndrome and the Liver: Current Insights.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">P Singh S, K Pati G. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Euroasian J Hepatogastroenterol. 2018 Jul-Dec; 8(2):140-147. Epub 2019 Feb 1.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30746957" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Alagille syndrome: an uncommon cause of intrahepatic cholestasis in adults.</a><span class="source">[Rev Esp Enferm Dig. 2019]</span><div class="brieflinkpop offscreen_noflow">Alagille syndrome: an uncommon cause of intrahepatic cholestasis in adults.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Zhang W, Zhao X, Huang J, Ou X, Jia J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Rev Esp Enferm Dig. 2019 Apr; 111(4):323-326. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301450" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301450" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040d6675f66d18aa979780">Alagille Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Alagille Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:31:18-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8B0917E03F35B100000000090C0344&amp;ncbi_session=CE8B0917E040D661_2316SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1273%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1273&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1273/&amp;ncbi_pagename=Alagille Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B0917E040D661_2316SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>